Site icon InvestyWise

Cholamandalam Addresses Allegations, Confirms Strong Financial Health

Cholamandalam Investment and Finance Company Limited (CIFCL) has addressed recent allegations, asserting they are malicious and baseless. The company reaffirms its strong financial health, with ₹14,900 crores in cash and bank balances as of November 30, 2025. CIFCL maintains an overall CAR of 19.79% and reassures investors of its continued performance and asset quality.

Response to Allegations

Cholamandalam Investment and Finance Company Limited (CIFCL) has responded to allegations made against the company and its associates, deeming them malicious and baseless with ulterior motives.

Financial Health and Liquidity

CIFCL emphasizes its robust financial health, with a strong liquidity position. As of November 30, 2025, the company holds ₹14,900 crores in cash and bank balances. The company’s asset quality remains solid, as reflected in its audited financial statements for the half-year ending September 2025 (Q2 FY26).

Capital Adequacy and Ratings

The company’s Capital Adequacy Ratio (CAR) stood at 19.79% as of November 30, 2025, with Tier I capital at 14.53%, exceeding the statutory requirements. CIFCL’s ratings remain at AA+ from ICRA, India Ratings, and CARE.

Clarifications on Queries

CIFCL addressed queries relating to financial practices and related party transactions:

Rejection of Claims

CIFCL categorically rejects claims of individuals benefitting improperly from company transactions, stating that all payments to Board members, KMP, and SMP comply with the law and have been disclosed to shareholders.

Queries regarding payments to rating agencies are addressed by stating that such payments are standard industry practice for all borrowings.

CSR contributions are made to NGOs/implementation agencies in the form of work contracts for monitoring implementation progress.

Source: BSE

Exit mobile version